AI assistant
CVS HEALTH Corp — Director's Dealing 2014
Jul 3, 2014
29875_dirs_2014-07-03_8028dddd-3c01-4ba6-b198-a1ab235db013.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2014-07-01
Reporting Person: Denton David M (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-01 | Common Stock | M | 26811 | $41.17 | Acquired | 113694.7692 | Direct |
| 2014-07-01 | Common Stock | M | 48178 | $28.10 | Acquired | 161872.7692 | Direct |
| 2014-07-01 | Common Stock | S | 74989 | $75.88 | Disposed | 86883.7692 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-01 | Stock Option | $41.17 | M | 26811 | Disposed | 2015-04-01 | Common Stock (26811) | Direct |
| 2014-07-01 | Stock Option | $28.10 | M | 48178 | Disposed | 2016-04-01 | Common Stock (48178) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 181662 | Direct |
| ESOP Common Stock | 1618.1203 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $40.28 | 2018-03-05 | Common Stock (12420) | 12420 | Direct |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (95618) | 95618 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (107178) | 107178 | Direct |
| Stock Option | $45.07 | 2019-04-02 | Common Stock (110912) | 110912 | Direct |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (108183) | 108183 | Direct |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (62943) | 62943 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $75.46 and $76.16 per share.
F3: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F4: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F5: Option became exercisable in three equal annual installments, commencing 3/5/2011.
F6: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F8: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F9: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2015.